Adeno-associated virus vectors for treatment of rett syndrome

NZ836045APending Publication Date: 2026-08-28SAREPTA THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ836045
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-08-19
Filing Date
2021-08-19
Publication Date
2026-08-28

Smart Images

  • Figure 1_ABST
    Figure 1_ABST
Patent Text Reader

Abstract

The disclosure provides nucleic acids (comprising AAV expression cassettes), AAV vectors, and compositions for use in methods for treating and / or delaying the onset of diseases associated with mutations in the mecp2 gene, such as Rett Syndrome. Also, provided herein are methods for treating and / or delaying the onset of brain-derived neurotrophic factor (BDNF)-associated diseases.
Need to check novelty before this filing date? Find Prior Art